docetaxel anhydrous has been researched along with Tumour Lysis Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, S; Varma, S | 1 |
| Nishimura, T; Oka, M; Takeda, S; Tokunou, K; Yoshino, S | 1 |
| Sorscher, SM | 1 |
| Ajzensztejn, D; Hegde, VS; Lee, SM | 1 |
4 other study(ies) available for docetaxel anhydrous and Tumour Lysis Syndrome
| Article | Year |
|---|---|
Rare incidence of tumor lysis syndrome in metastatic prostate cancer following treatment with docetaxel.
Topics: Aged; Antineoplastic Agents; Docetaxel; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Taxoids; Tumor Lysis Syndrome | 2018 |
[A case of esophageal cancer patient who developed tumor lysis syndrome after chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Taxoids; Tomography, X-Ray Computed; Tumor Lysis Syndrome | 2008 |
Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Male; Prostatic Neoplasms; Taxoids; Tumor Lysis Syndrome | 2004 |
Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Fatal Outcome; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Taxoids; Tumor Burden; Tumor Lysis Syndrome | 2006 |